Yep, it's also likely to be the approach for the other trials they're doing. Triple negative breast cancer, pancreatic cancers. All are horrible and don't have a lot of options available. Filling that need means a much quicker path to market and you're not up against a standard of care that's somewhat successful.
Yep, it's also likely to be the approach for the other trials...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $600.2M | |||
| Open | High | Low | Value | Volume |
| 8.2¢ | 8.3¢ | 8.2¢ | $74.59K | 909.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 175611 | 8.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.3¢ | 393872 | 10 |
View Market Depth
| Last trade - 10.10am 30/04/2024 (20 minute delay) ? |
|
|||||
|
Last
8.5¢ |
Change
0.000 ( 3.41 %) |
||||
| Open | High | Low | Volume | ||
| 8.2¢ | 8.5¢ | 8.2¢ | 1732284 | ||
| Last updated 10.23am 30/04/2024 ? | |||||
| IMU (ASX) Chart |